Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy

This study has been terminated.
(Parent protocol (SWOG S0816 / AMC-073) discontinued)
National Cancer Institute (NCI)
The EMMES Corporation
Information provided by (Responsible Party):
AIDS Malignancy Consortium Identifier:
First received: December 18, 2010
Last updated: October 1, 2015
Last verified: October 2015
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: January 2013
  Primary Completion Date: January 2013 (Final data collection date for primary outcome measure)